Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor beta chain variable regions Vβ3, Vβ14, and Vβ17 are structural domains of the β chain of the T-cell receptor, which is a membrane-bound heterodimer essential for antigen recognition by T cells[1][2][3]. The TCR Vβ region is highly diverse due to somatic recombination, allowing for an enormous range of antigen specificities[1]. Some Vβ domains—such as Vβ3, Vβ14, and Vβ17—are selectively expanded among autoreactive T cells in certain autoimmune diseases, suggesting their involvement in recognizing particular self-antigens presented by disease-associated MHC alleles[2][4]. Structural characterization of these Vβ regions provides insights into antigen specificity, immune tolerance, and breakdown in autoimmunity[2][3][4]. Monitoring and selectively targeting these Vβ regions can have diagnostic and potential therapeutic utility in diseases where pathogenic T cells have restricted Vβ usage[4].\n\nNote: The listing "Vβ3, Vβ14, and Vβ17" refers to related but distinct variable domains within the larger group of T-cell receptor β chain variable regions; each should be considered a separate molecular entity, but are often grouped in disease literature when assessing T-cell clonality or pathogenicity[2][4].
Targeted monoclonal antibodies may deplete pathogenic T cells expressing specific Vβ chains\nImmune modulation by selective T cell clone depletion or inactivation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor beta chain variable region 3, 14, or 17 (TCR Vβ3, TCR Vβ14, TCR Vβ17).